NMLSF (Restart Life Sciences) FCF Margin %: -55.10% (As of Mar. 2026)


What is Restart Life Sciences FCF Margin %?

Restart Life Sciences NMLSF FCF Margin % is -55.10% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, Restart Life Sciences ranks worse than 69.34% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Restart Life Sciences's Free Cash Flow for the three months ended in Mar. 2026 was $-0.05 Mil. Restart Life Sciences's Revenue for the three months ended in Mar. 2026 was $0.10 Mil. Therefore, Restart Life Sciences's FCF Margin % for the quarter that ended in Mar. 2026 was -55.10%.

As of today, Restart Life Sciences's current FCF Yield % is -10.09%.

The historical rank and industry rank for Restart Life Sciences's FCF Margin % or its related term are showing as below:

NMLSF' s FCF Margin % Range Over the Past 10 Years
Min: -12557.14   Med: -10174.03   Max: -412.24
Current: -412.24

During the past 13 years, the highest FCF Margin % of Restart Life Sciences was -412.24%. The lowest was -12557.14%. And the median was -10174.03%.

NMLSF's FCF Margin % is ranked worse than
69.34% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs NMLSF: -412.24

Restart Life Sciences FCF Margin % Related Terms

Restart Life Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Restart Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Restart Life Sciences FCF Margin % Chart

Restart Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Restart Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -55.10

NMLSF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Restart Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Restart Life Sciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Restart Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Restart Life Sciences's FCF Margin % falls into.


Restart Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Restart Life Sciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.52/0
= %

Restart Life Sciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.054/0.098
=-55.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -55.10% mean?
Restart Life Sciences (NMLSF) has a FCF Margin % of -55.10% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Restart Life Sciences and its competitors. According to the industry distribution chart, Restart Life Sciences ranks #665 out of 959 companies in the Biotechnology industry, placing it in the top 69.3%.
Is Restart Life Sciences' FCF Margin % too high?
Restart Life Sciences' current FCF Margin % is -55.10%. Based on the distribution chart, Restart Life Sciences ranks #665 out of 959 companies in the Biotechnology industry, which is below the industry midpoint.
How does Restart Life Sciences' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Restart Life Sciences ranks #665 out of 959 companies for FCF Margin %. This places Restart Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Restart Life Sciences and its competitors. Restart Life Sciences's current FCF Margin % is -55.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Restart Life Sciences stock overvalued right now?
Restart Life Sciences (NMLSF) has a current FCF Margin % of -55.10%. The current FCF Margin % is -55.10%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Restart Life Sciences (NMLSF), the current FCF Margin % is -55.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Restart Life Sciences Business Description

Other Exchanges HEAL:Canada
Address 700 - 838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian-based life sciences company dedicated to addressing health challenges with wellness solutions. Its brands include HolyCrap, BrainQ, Brain Balls.